EXOZYMES INC. Balance Sheet
EXOZ|1 years of annual SEC 10-K data (FY2024-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity. All figures from audited SEC 10-K filings.
EXOZYMES INC. had $13M in total assets with negative shareholders' equity of $384,319 as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 |
|---|---|
| Cash & Equivalents | $9.7M |
| Current Assets | $10.8M |
| PP&E (Net) | $882.4K |
| Total Assets | $13.0M |
| Current Liabilities | $1.3M |
| Shareholders' Equity | -$384.3K |